Results 31 to 40 of about 1,320,363 (167)

Malignant phyllodes tumor of the breast with heterologous osteosarcoma and chondrosarcomatous differentiation: A rare case report with imaging findings

Radiology Case Reports, 2023
Phyllodes tumors of the breast are rare fibroepithelial neoplasms accounting for 0.3%-1.5% of all female breast tumors [1,2]. Malignant transformations occur in 10%-20% of phyllodes tumors, often in the form of stroma.
Su Yeon Ko
doaj   +1 more source

Recurrent giant borderline phyllodes tumor: resection and breast reconstruction [PDF]

Revista Brasileira de Cirurgia Plástica
Phyllodes Tumor is a rare fibroepithelial neoplasm that represents 0.3 to 1% of all breast neoplasms. According to histopathologic classification, 12 to 26% are borderline type and approximately 15% of these tumors recur after surgical excision.
Elizbet Susan Montes-Madariaga, Brando Ortiz-Saavedra, Euler Altamirano-Farfan, Melissa Herencia-Anaya, Jimmy Pumamango-Cordova   +4 more
doaj   +1 more source

A massive malignant phyllodes tumor – case study [PDF]

, 2021
The paper aims to introduce the case of an extensive breast malignancy – phyllodes tumor. This type of breast neoplasm is relatively rare. Indeed, it accounts for only 0.3-1% of all breast malignant tumours.
Madej-Czerwonka Barbara, Madej-Czerwonka, Barbara, Barbara Madej-Czerwonka   +2 more
core   +1 more source

Recurrent malignant phyllodes tumor of the breast: An extremely rare case of recurrence with only rhabdomyosarcoma components

SAGE Open Medical Case Reports, 2022
Rhabdomyosarcoma is a rare disease that typically occurs in children. Rhabdomyosarcoma seldom occurs in the breast, and its diagnosis and treatment have infrequently been reported.
Jia Han, Shuice Liu, Akihoro Shioya, Motona Kumagai, Emi Morioka, Miki Noguchi, Masafumi Inokuchi, Sohsuke Yamada   +7 more
doaj   +1 more source

A giant exulcerated phyllodes breast tumor a case report [PDF]

, 2020
Phyllodes tumors of the breast can be benign, malignant, or borderline. Benign and borderline tumors are rare tumor types that have a positive outlook and high survival rate, while the risk of recurrence is typical for malignant breast tumors.
Mitrović Slobodanka, Marković Nenad, Jevđić Jasna, Milošević Bojan, Nedović Nikola, Spasić Marko, Marković Ivan, Kozomara Zoran, Jevtić Milica, Pavlović Mladen, Zornić Nenad, Ninković Srđan, Milisavljević Slobodan, Jevdjic, Jasna, Kozomara, Zoran, Pavlovic, Mladen, Nedovic, Nikola, Markovic, Nenad, Marković, Ivan, Zornic, Nenad, Spasic, Marko, Mitrović, Slobodanka, Milosevic, Bojan, Ninkovic, Srdjan, Milisavljevic, Slobodan, Jevtic, Milica   +25 more
core   +2 more sources

A huge phyllodes tumor in the breast: a case report

Electronic Physician, 2018
Phyllodes tumor is a benign breast cancer with a malignant potential. It is very rare in Saudi Arabia and also rare around the world. Malignant phyllodes tumors originate from the connective tissue of the breast, so they are histologically sarcomas. We
Ibrahim Altedlawi Albalawi
doaj   +1 more source

Omental Metastasis of Malignant Phyllodes Tumor: A Case Report [PDF]

, 2015
Malignant Phyllodes tumor behaves like sarcomas and has a tendency for local spread and for local recurrence. The metastasis commonly known is blood borne and is usually to the lungs, mediastinum and skeleton rather than to the axillary lymph nodes.
Nambiar, Ajit, Bhambhani, Navin, Pramesh, CS, Badwe, RA, Kulkarni, Chandrashekar, Gori, Jayesh   +5 more
core   +1 more source

Transcatheter arterial chemoembolization improves the resectability of malignant breast phyllodes tumor with angiosarcoma component: a case report

BMC Surgery, 2019
Background A giant phyllodes tumor of the breast is a rare fibroepithelial lesion, and its treatment is controversial. Many case reports have reported performing skin graft reconstruction after tumor excision.
Chih-Yu Kuo, Shing-Huey Lin, Kuan-Der Lee, Sho-Jen Cheng, Jan-Show Chu, Shih-Hsin Tu   +5 more
doaj   +1 more source

Spindle Cell Lesions of the Breast: A 12‐Year Experience

ANZ Journal of Surgery, EarlyView.
This 12‐year, single‐centre study examined 30 core‐biopsy‐diagnosed breast spindle cell lesions (BrSCL), classified as atypical (ASCL, n = 10) or bland (BSCL, n = 20). Following excision, 80% of ASCLs proved malignant, comprising sarcoma, malignant phyllodes tumour and metaplastic carcinoma.
Shalvin Jassal, Wesley Tjang, Shaun Monagle, Michael Law, Justin James   +4 more
wiley   +1 more source